News from milo biotechnology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 13, 2015, 09:05 ET First Duchenne Muscular Dystrophy Patient Treated in Follistatin Gene Therapy Trial

Milo Biotechnology announced the first Duchenne muscular dystrophy (DMD) patient was treated with follistatin gene therapy at Nationwide Children's...


Dec 03, 2014, 08:10 ET Milo Biotechnology Announces Patent Issuance

Milo Biotechnology, which is applying its follistatin gene therapy in three clinical programs, today announced the issuance of its parent patent...


Oct 20, 2014, 11:07 ET Milo Biotechnology's Follistatin Gene Therapy Increases Function in Becker Muscular Dystrophy Patients

Data published today in the journal Molecular Therapy demonstrates initial clinical proof of principle of a gene therapy to increase muscle strength...


Dec 12, 2012, 10:00 ET Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy

Milo Biotechnology today announced its AAV1-FS344 has been granted Orphan Drug designation from the FDA's Office of Orphan Products Development for...